Lead Collaborator definition

Lead Collaborator the lead investigator in respect of the Application at the Collaborator Institution. Liability: liability arising out of or in connection with this MTA, whether in contract, tort, misrepresentation, restitution, under statute or otherwise, including but not limited to arising from a breach of, or a failure to perform or defect or delay in performance of, any of a party’s obligations under this MTA, in each case howsoever caused, including if caused by negligence. Materials: the data as set out in Annex 4 supplied by UK Biobank to the Collaborator under or in connection with this MTA including any Participant Level Data. MTA: this Material Transfer Agreement, the Collaborator Terms and Conditions (including any documents and/or materials that are referred to in them), the Annexes and where applicable the contents of the Collaborator’s Application Form.
Sample 1Sample 2Sample 3
Lead Collaborator as used herein, means, for a Collaborative Effort, (a) MONSANTO, if the Product resulting from the Collaborative Effort relates to a DEKALB Crop; (b) DEKALB, if the Product resulting from the Collaborative Effort relates to a MONSANTO Crop; or (c) notwithstanding Subsections 2.19(a) and 2.19(b), the party which the parties mutually agree in writing shall be designated as the Lead Collaborator.
Sample 1
Lead Collaborator means [insert name of Party who is the leading Industrial Collaborator];
Sample 1

Examples of Lead Collaborator in a sentence

  • The Collaborator shall only be responsible for the conduct of the Lead Collaborator and any and all Collaborator Researchers involved in this Approved Research Project.

  • By signing this MTA, the Lead Collaborator confirms that the Security Measures set out in Annex 2 are in place in order to protect the Materials.

  • For the avoidance of doubt, the Lead Collaborator is not required to complete this form on execution of the MTA.

  • Specifically, the Lead Collaborator shall provide UK Biobank with such confirmation as part of the Annual Confirmation Form in the form attached at Annex 3.

  • The purpose of this Annex 3 is to provide the Lead Collaborator with a template of the Annual Confirmation Form that will need to be completed and submitted to UK Biobank on an annual basis (the annual anniversary of the Effective Date).

  • Collaborator Annual Confirmation Form Every year, the Lead Collaborator at each Collaborator Institution for a UK Biobank Research Project is required to provide some information regarding their project and confirmation that they are complying with the terms of the Material Transfer Agreement (MTA).

  • In all circumstances, the Collaborator, Lead Collaborator or any Collaborator Researcher shall: (i) obtain UK Biobank's written approval before responding to the Correspondence, including approval of the contents of any response; and (ii) subject to Data Protection Legislation, permit UK Biobank to respond directly to the Correspondence.

  • The Lead Collaborator is not a party to the MTA, however, UK Biobank requires the Lead Collaborator to sign the MTA to acknowledge that the provisions of this MTA have been “read and understood” so that they are fully aware of the Collaborator’s obligations to both UK Biobank and to UK Biobank’s Participants.

  • Lead Collaborator: the lead investigator at a Collaborator Institution.

  • The Lead Collaborator is not a party to the MTA; however, UK Biobank requires the Lead Collaborator to sign the MTA to acknowledge that the provisions of this MTA have been “read and understood” so that they are fully aware of the Collaborator’s obligations to both UK Biobank and to UK Biobank’s Participants.

Related to Lead Collaborator

  • Collaborator An individual who is not under the direct supervision of the PI (e.g., not a member of the PI’s laboratory) who assists with the PI’s research project involving controlled-access data subject to the NIH GDS Policy. Internal collaborators are employees of the Requester and work at the same location/campus as the PI. External collaborators are not employees of the Requester and/or do not work at the same location as the PI, and consequently must be independently approved to access controlled-access data subject to the NIH GDS Policy.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Research Program Term has the meaning set forth in Section 2.2.

  • GSK will have the meaning set forth in the Preamble.

  • Research Program has the meaning set forth in Section 2.1.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaborating physician means the physician who,

  • Collaboration Term has the meaning set forth in Section 2.2.

  • Lilly has the meaning set forth in the Preamble.

  • Collaboration has the meaning set forth in Section 2.1.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration IP means Collaboration Know-How and Collaboration Patents.

  • Joint Patent Committee or “JPC” has the meaning set forth in Section 7.1.3(a).

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • JPC means Joint Planning Committee.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • JDC has the meaning set forth in Section 3.2.

  • ISIS means the department’s individualized services information system.

  • JSC has the meaning set forth in Section 3.1.

  • Collaboration Technology means all Collaboration Patents and Collaboration Know-How.

  • Merck has the meaning set forth in the preamble.

  • Joint Research Committee or “JRC” has the meaning set forth in Section 3.1.1.

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;